2.1500
-0.1000
(-4.44%)
As of 11:11:44 AM GMT. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-3,768.0000
-3,768.0000
-3,805.0000
-4,594.0000
-5,152.0000
Investing Cash Flow
1.0000
1.0000
-8.0000
29.0000
1.0000
Financing Cash Flow
6,364.0000
6,364.0000
1,824.0000
6,575.0000
-456.0000
End Cash Position
5,188.0000
5,188.0000
2,601.0000
4,589.0000
2,574.0000
Capital Expenditure
-29.0000
-29.0000
-52.0000
-62.0000
-104.0000
Issuance of Capital Stock
6,253.0000
6,253.0000
1,685.0000
7,200.0000
46.0000
Repayment of Debt
--
--
--
--
-358.0000
Free Cash Flow
-3,797.0000
-3,797.0000
-3,857.0000
-4,656.0000
-5,256.0000
6/30/2021 - 4/4/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PRM.L Proteome Sciences plc
3.6200
-14.82%
EZB.BE Enzo Biochem Inc
0.6300
-2.33%
NN6.F NanoRepro AG
1.4200
-4.05%
IDHCl.XC
ESF0.MU Eurofins Scientific SE
50.22
0.00%
MVF.AX Monash IVF Group Limited
1.2150
+0.83%
VIMIAN.ST Vimian Group AB (publ)
38.40
+2.81%
DAP.DE Danaher Corporation
237.95
+1.21%
DAP.F Danaher Corporation
237.40
+1.22%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%